Venkat Kamalakar Bundla is the CEO–EU at Marksans Pharma, leveraging over three decades of leadership in the pharmaceutical and biotech sectors. A B. Pharm graduate and MBA, he co-founded Garphi Biosciences, a global advisory and investment platform, after holding senior roles at industry giants like Natco, Ranbaxy, and Aurobindo, specializing in strategy, M&A, and innovation.
Outside of his executive roles, Venkat is deeply committed to fostering the next generation of innovators through mentorship. He is an active angel investor in AI, medtech, and pharma startups and serves on the governing body of ABLE India, contributing to policy and ecosystem development within the life sciences sector.
He has traveled to over 80 countries, giving him a vast global network and strong expertise in multi-million dollar international deal-making.
Read the full overview →They are heavily focused on quality and prefer doing things the right way, even if it takes time. They are always well-planned and adopt a systematic approach. They tend to be clear about their needs and limitations and are unlikely to promise too much.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.